Multiplexed single-tier immunoassay for improved Lyme disease diagnosis across all disease stages
Open Access
- 9 February 2026
- journal article
Abstract
Lyme disease is the most common vector-borne infection in North America and Europe, yet current two-tier serologic testing shows poor sensitivity during early infection when antibiotic treatment is most effective. We developed and validated a single-tier multiplex immunoassay that combines ten Borrelia burgdorferi antigens with machine-learning classification to detect antibody responses across all disease stages. A total of 364 cases were obtained, which included well characterized prospective blood samples obtained during early infection. In a cohort of samples from the Johns Hopkins University SLICE studies, the classifier identified all 30 early Lyme disease cases and their 1–3-month post-treatment follow-up samples. To assess generalizability, an independent EU laboratory synthesized the antigens de novo and a distinct 259-person cohort was evaluated on newly built assays. The classifier achieved an AUC of 0.98 in both cohorts. This single-test platform delivers quantitative serologic classification using standard clinical laboratory instrumentation, addressing critical gaps in Lyme disease diagnosis.Keywords
This publication has 51 references indexed in Scilit:
- Temporal regulation of outer surface proteins of the Lyme-disease spirochaete Borrelia burgdorferiBiochemical Society Transactions, 2003
- Laboratory Diagnostic Techniques for Patients with Early Lyme Disease Associated with Erythema Migrans: A Comparison of Different TechniquesClinical Infectious Diseases, 2001
- Antibody Response to IR6, a Conserved Immunodominant Region of the VlsE Lipoprotein, Wanes Rapidly after Antibiotic Treatment ofBorrelia burgdorferiInfection in Experimental Animals and in HumansThe Journal of Infectious Diseases, 2001
- Two Controlled Trials of Antibiotic Treatment in Patients with Persistent Symptoms and a History of Lyme DiseaseNew England Journal of Medicine, 2001
- Sensitive and Specific Serodiagnosis of Lyme Disease by Enzyme-Linked Immunosorbent Assay with a Peptide Based on an Immunodominant Conserved Region ofBorrelia burgdorferiVlsEJournal of Clinical Microbiology, 1999
- Borrelia burgdorferi P35 and P37 Proteins, Expressed In Vivo, Elicit Protective ImmunityImmunity, 1997
- Surface exposure and species specificity of an immunoreactive domain of a 66-kilodalton outer membrane protein (P66) of the Borrelia spp. that cause Lyme diseaseInfection and Immunity, 1996
- The Long-Term Clinical Outcomes of Lyme Disease: A Population-Based Retrospective Cohort StudyAnnals of Internal Medicine, 1994
- Use of recombinant OspC from Borrelia burgdorferi for serodiagnosis of early Lyme diseaseJournal of Clinical Microbiology, 1994
- Serological follow-up after treatment of patients with erythema migrans and neuroborreliosisJournal of Clinical Microbiology, 1994